A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma
Background and Importance. In the last eight years temozolomide (TMZ) has been used as the last-line treatment modality for aggressive pituitary tumors to be applied after the failure of surgery, medical therapy, and radiotherapy. The objective was to achieve a rapid control of tumor growth and horm...
Saved in:
Main Authors: | Ana Misir Krpan, Tina Dusek, Zoran Rakusic, Mirsala Solak, Ivana Kraljevic, Vesna Bisof, David Ozretic, Darko Kastelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2017/2419590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progression of an Invasive ACTH Pituitary Macroadenoma with Cushing’s Disease to Pituitary Carcinoma
by: Clarissa Groberio Borba, et al.
Published: (2015-01-01) -
A Case of Nonfunctioning Pituitary Carcinoma That Responded to Temozolomide Treatment
by: Haruko Morokuma, et al.
Published: (2012-01-01) -
Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
by: Oscar D. Bruno, et al.
Published: (2015-01-01) -
MicroRNAs in Human Pituitary Adenomas
by: Xu-Hui Li, et al.
Published: (2014-01-01) -
Pituitary adenoma: a literature review
by: A. Sidaraitė, et al.
Published: (2018-03-01)